Glucotrack (GCTK) Net Cash Flow Growth (1y) (2011 - 2025)
Glucotrack (GCTK) Net Cash Flow Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.12 Bn | 120.90 Bn | 1.96 Bn | -9.88% |
| 2 | Becton Dickinson | 44.89 Bn | 44.07 Bn | 2.15 Bn | 131.47% |
| 3 | Alcon | 33.06 Bn | 31.40 Bn | 1.53 Bn | - |
| 4 | Medline | 32.81 Bn | 30.58 Bn | 1.84 Bn | -47.85% |
| 5 | Resmed | 29.44 Bn | 27.78 Bn | 890.98 Mn | -40.20% |
| 6 | West Pharmaceutical Services | 23.12 Bn | 22.68 Bn | 329.20 Mn | -196.55% |
| 7 | Solventum | 14.06 Bn | 13.50 Bn | 1.10 Bn | -41.07% |
| 8 | Cooper Companies | 13.87 Bn | 13.73 Bn | 735.40 Mn | 102.38% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | 84.02% |
| 10 | Glucotrack | 183,222.72 | -7.20 Mn | - | -108.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -108.74% |
| Sep 30, 2025 | -926.34% |
| Jun 30, 2025 | 121.68% |
| Mar 31, 2025 | 214.86% |
| Dec 31, 2024 | 319.16% |
| Sep 30, 2024 | 110.90% |
| Jun 30, 2024 | -101.15% |
| Mar 31, 2024 | -128.56% |
| Dec 31, 2023 | -157.86% |
| Sep 30, 2023 | -209.21% |
| Jun 30, 2023 | -4.15% |
| Mar 31, 2023 | -3.79% |
| Dec 31, 2022 | 4.30% |
| Sep 30, 2022 | 31.99% |
| Jun 30, 2022 | 5.47% |
| Mar 31, 2022 | -35.58% |
| Dec 31, 2021 | -14.81% |
| Sep 30, 2021 | -12.31% |
| Jun 30, 2021 | -7.31% |
| Mar 31, 2021 | -107.77% |